Literature DB >> 29756545

In Vitro and In Vivo Correlation of Bone Morphogenetic Protein-2 Release Profiles from Complex Delivery Vehicles.

Maurits G L Olthof1,2,3,4, Marianna A Tryfonidou4, Mahrokh Dadsetan1,2, Wouter J A Dhert4, Michael J Yaszemski1,2, Diederik H R Kempen5, Lichun Lu1,2.   

Abstract

Local sustained delivery of bioactive molecules from biomaterials is a promising strategy to enhance bone regeneration. To optimize delivery vehicles for bone formation, the design characteristics are tailored with consequential effect on bone morphogenetic protein-2 (BMP-2) release and bone regeneration. Complying with the 3R principles (Replacement, Reduction, and Refinement), the growth factor release is often investigated in vitro using several buffers to mimic the in vivo physiological environment. However, this remains an unmet need. Therefore, this study investigates the in vitro-in vivo correlation (IVIVC) of BMP-2 release from complex delivery vehicles in several commonly used in vitro buffers: cell culture model, phosphate buffered saline, and a strong desorption buffer. The results from this study showed that the release environment affected the BMP-2 release profiles, creating distinct relationships between release versus time and differences in extent of release. According to the guidance set by the U.S. Food and Drug Administration (FDA), IVIVC resulted in level A internal predictability for individual composites. Since the IVIVC was influenced by the BMP-2 loading method and composite surface chemistry, the external predictive value of the IVIVCs was limited. These results show that the IVIVCs can be used for predicting the release of an individual composite. However, the models cannot be used for predicting in vivo release for different composite formulations since they lack external predictability. Potential confounding effects of drug type, delivery vehicle formulations, and application site should be added to the equation to develop one single IVIVC applicable for complex delivery vehicles. Altogether, these results imply that more sophisticated in vitro systems should be used in bone regeneration to accurately discriminate and predict in vivo BMP-2 release from different complex delivery vehicles.

Entities:  

Keywords:  bone morphogenetic protein-2 release; bone regeneration; in vitro-in vivo correlation; oligo(polyethelene glycol) fumarate

Mesh:

Substances:

Year:  2018        PMID: 29756545      PMCID: PMC6056261          DOI: 10.1089/ten.TEC.2018.0024

Source DB:  PubMed          Journal:  Tissue Eng Part C Methods        ISSN: 1937-3384            Impact factor:   3.056


  36 in total

1.  In vitro and in vivo degradation of porous poly(DL-lactic-co-glycolic acid) foams.

Authors:  L Lu; S J Peter; M D Lyman; H L Lai; S M Leite; J A Tamada; S Uyama; J P Vacanti; R Langer; A G Mikos
Journal:  Biomaterials       Date:  2000-09       Impact factor: 12.479

2.  Osteogenic effect of local, long versus short term BMP-2 delivery from a novel SPU-PLGA-βTCP concentric system in a critical size defect in rats.

Authors:  M Rodríguez-Évora; A Delgado; R Reyes; A Hernández-Daranas; I Soriano; J San Román; C Evora
Journal:  Eur J Pharm Sci       Date:  2013-06-21       Impact factor: 4.384

3.  Phosphate Functional Groups Improve Oligo[(Polyethylene Glycol) Fumarate] Osteoconduction and BMP-2 Osteoinductive Efficacy.

Authors:  Maurits G L Olthof; Marianna A Tryfonidou; Xifeng Liu; Behdad Pouran; Björn P Meij; Wouter J A Dhert; Michael J Yaszemski; Lichun Lu; Jacqueline Alblas; Diederik H R Kempen
Journal:  Tissue Eng Part A       Date:  2018-04-23       Impact factor: 3.845

4.  Material-related effects of BMP-2 delivery systems on bone regeneration.

Authors:  Antonio Hernández; Esther Sánchez; Isabel Soriano; Ricardo Reyes; Araceli Delgado; Carmen Évora
Journal:  Acta Biomater       Date:  2011-10-13       Impact factor: 8.947

5.  Controlled release of growth factors based on biodegradation of gelatin hydrogel.

Authors:  M Yamamoto; Y Ikada; Y Tabata
Journal:  J Biomater Sci Polym Ed       Date:  2001       Impact factor: 3.517

6.  Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration.

Authors:  Diederik H R Kempen; Lichun Lu; Andras Heijink; Theresa E Hefferan; Laura B Creemers; Avudaiappan Maran; Michael J Yaszemski; Wouter J A Dhert
Journal:  Biomaterials       Date:  2009-02-20       Impact factor: 12.479

7.  Retention of in vitro and in vivo BMP-2 bioactivities in sustained delivery vehicles for bone tissue engineering.

Authors:  Diederik H R Kempen; Lichun Lu; Teresa E Hefferan; Laura B Creemers; Avudaiappan Maran; Kelly L Classic; Wouter J A Dhert; Michael J Yaszemski
Journal:  Biomaterials       Date:  2008-05-09       Impact factor: 12.479

8.  Importance of single or blended polymer types for controlled in vitro release and plasma levels of a somatostatin analogue entrapped in PLA/PLGA microspheres.

Authors:  María J Blanco-Príeto; Miguel A Campanero; Kamel Besseghir; F Heimgatner; Bruno Gander
Journal:  J Control Release       Date:  2004-05-18       Impact factor: 9.776

9.  Controlled release by biodegradable hydrogels enhances the ectopic bone formation of bone morphogenetic protein.

Authors:  Masaya Yamamoto; Yoshitake Takahashi; Yasuhiko Tabata
Journal:  Biomaterials       Date:  2003-11       Impact factor: 12.479

Review 10.  Tissue engineered bone using select growth factors: A comprehensive review of animal studies and clinical translation studies in man.

Authors:  D Gothard; E L Smith; J M Kanczler; H Rashidi; O Qutachi; J Henstock; M Rotherham; A El Haj; K M Shakesheff; R O C Oreffo
Journal:  Eur Cell Mater       Date:  2014-10-06       Impact factor: 3.942

View more
  2 in total

1.  Effect of Biomaterial Electrical Charge on Bone Morphogenetic Protein-2-Induced In Vivo Bone Formation.

Authors:  Maurits G L Olthof; Diederik H R Kempen; Xifeng Liu; Mahrokh Dadsetan; Marianna A Tryfonidou; Michael J Yaszemski; Wouter J A Dhert; Lichun Lu
Journal:  Tissue Eng Part A       Date:  2019-06-14       Impact factor: 3.845

2.  Engineered bridge protein with dual affinity for bone morphogenetic protein-2 and collagen enhances bone regeneration for spinal fusion.

Authors:  Priscilla S Briquez; Hsiu-Ming Tsai; Elyse A Watkins; Jeffrey A Hubbell
Journal:  Sci Adv       Date:  2021-06-11       Impact factor: 14.136

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.